Comparative Study of Reducing Jaundice Treatment of Advanced Hilar Cholangiocarcinoma

Zhang Dong,Tao Jie,Bai Jigang,Shi Lei,Sun Hao,Wang Lin,Geng Zhimin
DOI: https://doi.org/10.3877/cma.j.issn.1674-6899.2017.05.021
2017-01-01
Abstract:Objective To investigate the efficacy and difference of endoscopic retrograde cholangio pancreatography(ERCP)and percutaneous transhepatic biliary drainage (PTBD ) in the treatment of advanced hilar cholangiocarcinoma. Methods The clinical data of 113 patients with hilar cholangiocarcinoma admitted to the department of hepatobiliary surgery of the First Affiliated Hospital of Xi′an Jiao Tong University from Jan.2003 to Dec.2013 were retrospectively analyzed.All patients signed informed consent,in accordance with the provisions of medical ethics.There were 63 males and 50 females, average age 29-83 years old.Analysis of the treatment and the effect of reducing jaundice,postoperative complications and patient survival.Results In 113 patients with advanced hilar cholangiocarcinoma, 42 cases were treated with ERCP + biliary stent implantation and 71 cases with PTBD.In the overall subtraction therapy,the effective yellow rate in ERCP and PTBD groups was 85.7% and 85.9%, respectively,and there was no significant difference between the two groups (P >0.05).ERCP group of postoperative cholangitis incidence rate was 38.1%,significantly higher than 14.1% in group PTBD (P <0.01);the incidence of 2.4% biliary tract hemorrhage after operation in ERCP group,PTBD group was 15.5%,there was significant difference among the two groups (P <0.01);ERCP group of postoperative liver failure occurred in 9.5%,14.1% in PTBD group,no see a significant difference between the two groups (P >0.05).The results of jaundice treatment for 7 months,and give up 3 months of treatment group was significantly prolonged the survival time of the patients;there was no significant difference between ERCP group and PTBD group (P > 0.05 ).Conclusions To improve the diagnosis and treatment of advanced hilar cholangiocarcinoma and improve survival therapy,effective jaundice reduction treatment is needed to improve the survival time of patients.The first choice of ERCP reduction therapy can improve the postoperative quality of life.
What problem does this paper attempt to address?